Al specialises in EU and UK competition law. His clients include the AA, the DfT, Saga, Tate & Lyle and William Hill.
Al recently advised Alliance Medical on its acquisition of IBA Molecular (securing unconditional Phase II clearance from the Competition and Markets Authority) and Tate & Lyle on the restructuring of its bulk products business (which required six international filings).
Recent market investigation experience includes acting for a clearing bank on the Competition and Market Authority's retail banking investigation and a main party on the Competition Commission's investigation into private motor insurance.
Al also regularly advises both government and private institutions on State aid (including liaising with monitoring trustees). He has significant recent experience of making successful leniency applications.
He has particular expertise in payment systems and sits on AG's cross-divisional payments team. He has advised a number of major payments institutions on the impact of the interchange regulation, new rules on surcharging and the UK's Payment Systems Regulator. He also acted for a clearing bank in relation to the EC's investigation into the standardisation of epayments.